Importantly, EcSODR213G mice had greater kidney injury along with more profound endothelial cell activation following LPS-induce endotoxemia, supporting that systemic administration of EcSOD is sufficient to protect against kidney injury [12]. This evidence concerns the gene SOD3 and serum lipopolysaccharide activity.